O-glycosylation as a potential biomarker in Alzheimer’s disease
EXCLI Journal · 07.10.2025 · 24 · 1347-1351
DOI: 10.17179/excli2025-8717 ↗Kurz gefasst
Leserbrief in der Zeitschrift EXCLI Journal, online erschienen am 07.10.2025. Verfasst von Parteek Prasher und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Petroleum & Energy Studies, Energy Acres, Dehradun 248007, India. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Besides amyloid-β and tau pathology as contemporary biomarkers for monitoring the AD progression, the clinical evidence identified the diagnostic value of post translational modifications, particularly O-glycosylation signature as an emerging tool for the detection, and as a potential treatment intervention, owing to its association with protein folding, Aβ aggregation, APP processing, signal transduction, and synaptic functioning in AD pathogenesis. Anomalous O-glycosylation fingerprints detected in the CSF and brain tissues of AD patients and animal models have been associated with the hallmark pathological features in AD, thereby presenting a promising potential as candidate biomarkers in the early-stage detection and diagnosis of the disease. The research on O-glycosylation linked AD progression is although in its infantile stage with a limited clinical and preclinical evidence, there is a pressing need for targeted investigations into O-glycosylated proteins while including multi-omics strategies for redefining their role AD diagnosis and risk stratification.
Autor:innen und Institutionen
- Department of Chemistry, University of Petroleum & Energy Studies, Energy Acres, Dehradun 248007, India.
- Department of Chemistry, Uttaranchal University, Dehradun 248007, India.
Zitieren
APA
Prasher, P., & Sharma, M. (2025). O-glycosylation as a potential biomarker in Alzheimer’s disease. EXCLI Journal, 24, 1347-1351. https://doi.org/10.17179/excli2025-8717
Vancouver
Prasher P, Sharma M. O-glycosylation as a potential biomarker in Alzheimer’s disease. EXCLI Journal. 2025;24:1347-1351. doi:10.17179/excli2025-8717
BibTeX
@article{Prasher2025,
author = {Prasher, Parteek and Sharma, Mousmee},
title = {O-glycosylation as a potential biomarker in Alzheimer’s disease},
journal = {EXCLI Journal},
year = {2025},
volume = {24},
pages = {1347--1351},
doi = {10.17179/excli2025-8717}
}
EUVIMED